Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Criteo S.A. Director's Dealing 2024

Sep 16, 2024

32108_dirs_2024-09-16_38c17612-e796-4335-a5b0-288dbc581c01.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Criteo S.A. (CRTO)
CIK: 0001576427
Period of Report: 2024-09-12

Reporting Person: Damon Ryan (Chief Legal Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-12 Ordinary Shares M 16845 $20.66 Acquired 138064 Direct
2024-09-12 Ordinary Shares S 16845 $44.37 Disposed 121219 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-09-12 Stock Option (right to buy) $20.66 M 16845 Disposed 2028-10-25 Ordinary Shares (16845) Direct

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.

F2: The exercise price of the stock option is 18.72 euros. The U.S. dollar equivalent of the exercise price is $20.66 using the exchange rate as of September 12, 2024 (1.00 = $1.1035).

F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

F4: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $44.24 to $44.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F5: Stock options granted on October 25, 2018. One-fourth of the grant vests on the first anniversary of the grant date and additional 1/16th of the grant vests quarterly thereafter for a period of 36 months, subject to continued service through each vesting date.